{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:55:16Z","timestamp":1781762116140,"version":"3.54.5"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Neonatal hyperglycemia affects up to 80% of extremely low birth weight (ELBW) infants and is independently associated with mortality, intraventricular hemorrhage, and adverse neurodevelopmental outcomes. Intravenous insulin infusion, which is the standard of care, requires dedicated vascular access. To the best of our knowledge, this is the first report of combined continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) in an ELBW infant (birth weight &amp;lt;1,000\u2005g). Transient hyperglycemia developed on day of life (DOL) 2, necessitating insulin therapy. A 55-min intravenous bridge facilitated the transition to a subcutaneous sensor-augmented pump system (Medtronic MiniMed 780G; Guardian\u202f4 CGM sensor; insulin aspart, undiluted). Given a subcutaneous adipose tissue depth of approximately 1\u20132\u2005mm, standard insertion devices were not applicable; tangential near-horizontal manual insertion by a physician achieved reliable subcutaneous positioning. Over 14 days, 3,931 CGM measurements were recorded; the mean glucose level was 162\u2009\u00b1\u200957\u2005mg\/dL (9.0\u2009\u00b1\u20093.2\u2005mmol\/L), and the time in the target range (62\u2013180\u2005mg\/dL; 3.4\u201310.0\u2005mmol\/L) was 59.4%. CGM reduced the number of invasive reference glucose measurements from an estimated 84\u2013168 to 20, representing a 76%\u201388% reduction in cutaneous punctures. Infusion set occlusion on DOL\u202f6 was identified prospectively using CGM trend analysis. Combined CGM and CSII were maintained uninterrupted throughout laparotomy for focal intestinal perforation, allowing real-time perioperative glycemic surveillance and proactive insulin dose titration without additional invasive procedures. Insulin therapy was discontinued on DOL\u202f17 as glucose levels normalized. This case establishes proof-of-concept for sensor-augmented subcutaneous insulin pump therapy at the physiological extreme of viability, providing a procedural foundation for neonatal-adapted closed-loop trials.<\/jats:p>","DOI":"10.3389\/fped.2026.1858894","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:36:30Z","timestamp":1781760990000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Subcutaneous sensor-augmented insulin pump therapy in a 510-g preterm infant with hyperglycemia"],"prefix":"10.3389","volume":"14","author":[{"given":"Christian","family":"Schlunk","sequence":"first","affiliation":[{"name":"Department of Neonatology, Olgahospital, Klinikum Stuttgart","place":["Stuttgart, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Neuberger","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Olgahospital, Klinikum Stuttgart","place":["Stuttgart, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"K\u00fcnle","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology and Diabetology, Olgahospital, Klinikum Stuttgart","place":["Stuttgart, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Holder","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology and Diabetology, Olgahospital, Klinikum Stuttgart","place":["Stuttgart, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neysan","family":"Rafat","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Olgahospital, Klinikum Stuttgart","place":["Stuttgart, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"F126","DOI":"10.1136\/adc.2008.154716","article-title":"Management of hyperglycaemia in the preterm infant","volume":"95","author":"Ogilvy-Stuart","year":"2010","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e584","DOI":"10.1542\/peds.2009-0449","article-title":"Early hyperglycemia is a risk factor for death and white matter reduction in preterm infants","volume":"125","author":"Alexandrou","year":"2010","journal-title":"Pediatrics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1542\/peds.2006-0628","article-title":"Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants","volume":"118","author":"Hays","year":"2006","journal-title":"Pediatrics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1056\/NEJMoa0803725","article-title":"Early insulin therapy in very-low-birth-weight infants","volume":"359","author":"Beardsall","year":"2008","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"CD007453","DOI":"10.1002\/14651858.CD007453.pub3","article-title":"Interventions for treatment of neonatal hyperglycemia in very low birth weight infants","volume":"10","author":"Bottino","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.diabres.2008.02.013","article-title":"Adsorption of insulin onto infusion sets used in adult intensive care unit and neonatal care settings","volume":"80","author":"Zahid","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/1932296819876924","article-title":"Capacity of infusion lines for insulin adsorption: effect of flow rate on total adsorption","volume":"15","author":"Knopp","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1046\/j.1440-1754.2000.00488.x","article-title":"Insulin infusions in the neonatal unit: delivery variation due to adsorption","volume":"36","author":"Hewson","year":"2000","journal-title":"J Paediatr Child Health"},{"key":"B9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13052-018-0542-5","article-title":"Continuous glucose monitoring in very low birth weight newborns needing parenteral nutrition: validation and glycemic percentiles","volume":"44","author":"Perri","year":"2018","journal-title":"Ital J Pediatr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e20171162","DOI":"10.1542\/peds.2017-1162","article-title":"Continuous glucose monitoring in very preterm infants: a randomized controlled trial","volume":"140","author":"Galderisi","year":"2017","journal-title":"Pediatrics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S2352-4642(20)30367-9","article-title":"Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial","volume":"5","author":"Beardsall","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000521695","article-title":"Efficiency of continuous subcutaneous insulin infusion for premature neonate: a case report","volume":"119","author":"Desenfants","year":"2022","journal-title":"Neonatology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s44253-023-00004-3","article-title":"Continuous subcutaneous insulin infusion via an insulin pump in extremely premature neonates\u2014a case series","volume":"1","author":"Becocci","year":"2023","journal-title":"Intensive Care Med Paediatr Neonatal"},{"key":"B14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4274\/jcrpe.galenos.2024.2024-2-9","article-title":"Treatment of severe hyperglycemia in extremely preterm infants using continuous subcutaneous insulin therapy","volume":"16","author":"B\u00f6ettger","year":"2024","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0025","DOI":"10.5041\/RMMJ.10132","article-title":"Neonatal pain in very preterm infants: long-term effects on brain, neurodevelopment and pain reactivity","volume":"4","author":"Grunau","year":"2013","journal-title":"Rambam Maimonides Med J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"F279","DOI":"10.1136\/archdischild-2019-316871","article-title":"Feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants","volume":"105","author":"Beardsall","year":"2020","journal-title":"Arch Dis Child Fetal Neonatal Ed"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1858894\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:36:31Z","timestamp":1781760991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1858894\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":16,"alternative-id":["10.3389\/fped.2026.1858894"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1858894","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"article-number":"1858894"}}